REGULATION OF CD28 SIGNAL TRNSDUCTION
REGULATION OF CD28 SIGNAL TRNSDUCTION
批准号:
6511069
负责人:
PHILIP D KING
金额:
$17.85万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2002-11-30
中文摘要
描述(改编自研究者摘要):在
对外来抗原的应答T细胞必须接受TCR信号和
共刺激信号。重要的T细胞共刺激受体是
CD 28分子还具有保护T细胞免受
抗原诱导无能和凋亡。除了对下列问题的答复之外,
外源抗原T细胞需要CD 28信号来启动有害的
自身免疫性疾病中对自身抗原的反应。因此,一种能力
特异性操纵CD 28信号将代表一种有效的
控制这些异常免疫反应的方法。以识别
治疗的潜在分子靶点,
建议是了解CD 28细胞内信号传导的本质
途径。先前的研究已经确定,CD 28信号转导涉及
PI 3-激酶和Grb-2向酪氨酸磷酸化的CD 28的募集
胞质尾然而,有证据表明,其他信号
分子被募集到CD 28尾部,这些分子发挥着
在CD 28信号转导中的重要作用。最近,额外的CD 28
鉴定了结合蛋白。一个是以前没有描述过的双重-
MAP激酶磷酸酶家族的特异性磷酸酶MKP 5,
不依赖于酪氨酸磷酸化而结合CD 28尾。另一个是
GRAP衔接蛋白,其与Grb-2相关但不同,
并且也仅结合磷酸化的CD 28尾。初步证据
表明MKP 5作为CD 28信号的负调节剂起作用
转导相反,GRAP可能在CD 28中起积极作用,
发信号。具体地,这里建议使用各种
分子遗传学、生物化学和细胞技术,以1)确认
MKP 5和GRAP分别具有负和正信号传导作用,
和2)确定这些分子在CD 28中的精确功能。
信号转导途径此外,使用一种新的基于酵母的
遗传分析,已在实验室开发,它建议
为了表征结合所述抗体的其他信号传导中间体,
磷酸化的CD 28胞质尾区。
英文摘要
DESCRIPTION (Adapted from Investigator's Abstract): To proliferate in
response to foreign antigens T cells must receive both TCR signals and
co-stimulatory signals. An important T cell co-stimulatory receptor is
the CD28 molecule that additionally functions to protect T cells from
antigen induced anergy and apoptosis. In addition to responses to
foreign antigens T cells require CD28 signals to initiate harmful
responses to self antigens in autoimmune disease. Therefore, an ability
to specifically manipulate CD28 signals would represent an effective
means of controlling these aberrant immune responses. To identify
potential molecular targets for therapy the long-term aims of this
proposal are to understand the nature of CD28 intracellular signaling
pathways. Previous studies have determined that CD28 signaling involves
recruitment of PI3-kinase and Grb-2 to the tyrosine phosphorylated CD28
cytoplasmic tail. However, there is evidence that other signaling
molecules are recruited to the CD28 tail and that these molecules play
important roles in CD28 signal transduction. Recently, additional CD28
binding proteins were identified. One is a previously un-described dual-
specific phosphatase of the MAP kinase phosphatase family, MKP5, which
binds the CD28 tail independent of tyrosine phosphorylation. Another is
the GRAP adaptor protein, which is related to but distinct from Grb-2,
and also binds only the phosphorylated CD28 tail. Preliminary evidence
indicates that MKP5 functions as a negative regulator of CD28 signal
transduction. In contrast, GRAP likely performs a positive role in CD28
signaling. Specifically, here it is proposed to use a variety of
molecular genetic, biochemical and cellular techniques to 1) Confirm
negative and positive signaling roles for MKP5 and GRAP respectively,
and 2) Determine the precise function of these molecules in the CD28
signal transduction pathway. In addition, using a novel yeast-based
genetic assay that has been developed in the laboratory, it is proposed
to characterize other signaling intermediates that bind the
phosphorylated CD28 cytoplasmic tail.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells
-
批准号:10412160
-
项目类别:
-
资助金额:$65.25万
-
财政年份:2022
-
负责人:PHILIP D KING
-
依托单位:
Roles of Macropinocytosis in HIV-1 infection of CD4+ T Cells
-
批准号:10652492
-
项目类别:
-
资助金额:$64.25万
-
财政年份:2022
-
负责人:PHILIP D KING
-
依托单位:
The Structure and Function of Dental Lymphatics (R21)
-
批准号:10388309
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2021
-
负责人:PHILIP D KING
-
依托单位:
Molecular pathogenetic mechanisms in CM-AVM
-
批准号:9883235
-
项目类别:
-
资助金额:$60.32万
-
财政年份:2020
-
负责人:PHILIP D KING
-
依托单位:
Molecular pathogenetic mechanisms in CM-AVM
-
批准号:10534770
-
项目类别:
-
资助金额:$51.88万
-
财政年份:2020
-
负责人:PHILIP D KING
-
依托单位:
Molecular pathogenetic mechanisms in CM-AVM
-
批准号:10319562
-
项目类别:
-
资助金额:$51.88万
-
财政年份:2020
-
负责人:PHILIP D KING
-
依托单位:
Lymphatic Vessel Abnormalities in CM-AVM
-
批准号:8884207
-
项目类别:
-
资助金额:$39.72万
-
财政年份:2015
-
负责人:PHILIP D KING
-
依托单位:
EPHB4-RASA1 regulation of lymphatic vessel valve development and function
-
批准号:10543485
-
项目类别:
-
资助金额:$57.12万
-
财政年份:2015
-
负责人:PHILIP D KING
-
依托单位:
Lymphatic Vessel Abnormalities in CM-AVM
-
批准号:9034658
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2015
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:8308412
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:7688995
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:8126210
-
项目类别:
-
资助金额:$35.77万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
RASA1-mediated control of lymphatic vessel growth and function
-
批准号:7903263
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2009
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:7083748
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6751203
-
项目类别:
-
资助金额:$28.19万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6544850
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6908115
-
项目类别:
-
资助金额:$29.08万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6697024
-
项目类别:
-
资助金额:$16.18万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
Control of T cell activation by the TSAd adapter protein
-
批准号:6640313
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2002
-
负责人:PHILIP D KING
-
依托单位:
REGULATION OF CD28 SIGNAL TRNSDUCTION
-
批准号:6362394
-
项目类别:
-
资助金额:$20.9万
-
财政年份:1999
-
负责人:PHILIP D KING
-
依托单位:
海外基金